1. Home
  2. ABBV
  3. ABBV News

Latest AbbVie Inc. (ABBV) News on February 23, 2025

4 Seniors & Aging Demographics Stocks to Watch Right Now
ABBV

Zacks

2 days ago

4 Seniors & Aging Demographics Stocks to Watch Right Now

Some May Be Optimistic About AbbVie's (NYSE:ABBV) Earnings
ABBV

Simply Wall St.

2 days ago

Some May Be Optimistic About AbbVie's (NYSE:ABBV) Earnings

2 Magnificent Dividend Growth Stocks to Load Up On Right Now
ABBV

Motley Fool

3 days ago

2 Magnificent Dividend Growth Stocks to Load Up On Right Now

ABBV

MT Newswires

4 days ago

AbbVie Prices $4 Billion of Senior Notes

Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent
ABBV

Yahoo Finance

4 days ago

Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent

The Art of Valuation: Discovering AbbVie Inc's Intrinsic Value
ABBV

GuruFocus.com

4 days ago

The Art of Valuation: Discovering AbbVie Inc's Intrinsic Value

Top Analyst Reports for Home Depot, Booking & Eaton
ABBV

Zacks

4 days ago

Top Analyst Reports for Home Depot, Booking & Eaton

Why AbbVie Inc. (ABBV) Is One of the Best Drug Stocks to Buy Now
ABBV

Insider Monkey

6 days ago

Why AbbVie Inc. (ABBV) Is One of the Best Drug Stocks to Buy Now

AbbVie Full Year 2024 Earnings: EPS Misses Expectations
ABBV

Simply Wall St.

7 days ago

AbbVie Full Year 2024 Earnings: EPS Misses Expectations

Is AbbVie Stock a Buy Now?
ABBV

Motley Fool

8 days ago

Is AbbVie Stock a Buy Now?

Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs
ABBV

Zacks

9 days ago

Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs

ABBV

MT Newswires

9 days ago

AbbVie CEO Robert Michael to Succeed Richard Gonzalez as Chair

AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
ABBV

PR Newswire

9 days ago

AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors

AbbVie Declares Quarterly Dividend
ABBV

PR Newswire

10 days ago

AbbVie Declares Quarterly Dividend

AbbVie Inc. (ABBV): Among Lee Munder Capital Group’s Top Stock Picks
ABBV

Insider Monkey

10 days ago

AbbVie Inc. (ABBV): Among Lee Munder Capital Group’s Top Stock Picks

Neumora shakes up its C-suite; Biogen cuts early-stage pipeline
ABBV

BioPharma Dive

10 days ago

Neumora shakes up its C-suite; Biogen cuts early-stage pipeline

Is AbbVie Inc. (NYSE:ABBV) Trading At A 47% Discount?
ABBV

Simply Wall St.

10 days ago

Is AbbVie Inc. (NYSE:ABBV) Trading At A 47% Discount?

AbbVie and Xilio to collaborate on antibody-based immunotherapies
ABBV

Pharmaceutical Technology

10 days ago

AbbVie and Xilio to collaborate on antibody-based immunotherapies

Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday?
ABBV

Benzinga

11 days ago

Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday?

Allergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training
ABBV

PR Newswire

11 days ago

Allergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training

ABBV

MT Newswires

11 days ago

AbbVie, Xilio Collaborate on Tumor-Activated Immunotherapies

ABBV

GlobeNewswire

11 days ago

AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies

Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs Warns
ABBV

Benzinga

11 days ago

Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs Warns

Biogen (BIIB) Reports Earnings Tomorrow: What To Expect
ABBV

StockStory

12 days ago

Biogen (BIIB) Reports Earnings Tomorrow: What To Expect

Navigating Market Uncertainty: Intrinsic Value of AbbVie Inc
ABBV

GuruFocus.com

12 days ago

Navigating Market Uncertainty: Intrinsic Value of AbbVie Inc

Gilead Sciences (GILD) Q4 Earnings: What To Expect
ABBV

StockStory

13 days ago

Gilead Sciences (GILD) Q4 Earnings: What To Expect

AbbVie, Pfizer gain FDA OK for novel antibiotic
ABBV

BioPharma Dive

13 days ago

AbbVie, Pfizer gain FDA OK for novel antibiotic

Is Invesco Large Cap Value ETF (PWV) a Strong ETF Right Now?
ABBV

Zacks

13 days ago

Is Invesco Large Cap Value ETF (PWV) a Strong ETF Right Now?

FDA approves AbbVie’s Emblaveo for intra-abdominal infections
ABBV

Pharmaceutical Technology

13 days ago

FDA approves AbbVie’s Emblaveo for intra-abdominal infections

3 Fabulous Dividend Stocks to Buy in February
ABBV

Motley Fool

13 days ago

3 Fabulous Dividend Stocks to Buy in February

Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look For
ABBV

StockStory

14 days ago

Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look For

Earnings To Watch: Incyte (INCY) Reports Q4 Results Tomorrow
ABBV

StockStory

14 days ago

Earnings To Watch: Incyte (INCY) Reports Q4 Results Tomorrow

3 Dividend Stocks to Double Up on Right Now
ABBV

Motley Fool

14 days ago

3 Dividend Stocks to Double Up on Right Now

These 2 Dividend Stocks Are Absolute Bargains Right Now
ABBV

Motley Fool

15 days ago

These 2 Dividend Stocks Are Absolute Bargains Right Now

ABBV

MT Newswires

15 days ago

AbbVie Says FDA Approves Emblaveo Antibiotic to Treat Abdominal Infections

U.S. FDA Approves EMBLAVEO™ (aztreonam and avibactam) for the Treatment of Adults With Complicated Intra-Abdominal Infections With Limited or No Treatment Options
ABBV

PR Newswire

16 days ago

U.S. FDA Approves EMBLAVEO™ (aztreonam and avibactam) for the Treatment of Adults With Complicated Intra-Abdominal Infections With Limited or No Treatment Options

Pharma Stock Roundup: PFE, LLY, NVO, LLY and AZN's Q4 Earnings Update
ABBV

Zacks

16 days ago

Pharma Stock Roundup: PFE, LLY, NVO, LLY and AZN's Q4 Earnings Update

3 US Stocks Estimated To Be Undervalued In February 2025
ABBV

Simply Wall St.

16 days ago

3 US Stocks Estimated To Be Undervalued In February 2025

The Zacks Analyst Blog Walmart, Visa, AbbVie and AstroNova
ABBV

Zacks

16 days ago

The Zacks Analyst Blog Walmart, Visa, AbbVie and AstroNova

Earnings Season Scorecard and Fresh Research Reports for Walmart, Visa & AbbVie
ABBV

Zacks

17 days ago

Earnings Season Scorecard and Fresh Research Reports for Walmart, Visa & AbbVie

3 Top AI-Powered Biotech Stocks to Buy in February
ABBV

Motley Fool

17 days ago

3 Top AI-Powered Biotech Stocks to Buy in February

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
ABBV

Zacks

17 days ago

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

Allergan Aesthetics Invites Consumers to Join the Faces of Natrelle® Campaign
ABBV

PR Newswire

17 days ago

Allergan Aesthetics Invites Consumers to Join the Faces of Natrelle® Campaign

Supernus wins FDA approval for Parkinson’s pump on fourth try
ABBV

Pharmaceutical Technology

17 days ago

Supernus wins FDA approval for Parkinson’s pump on fourth try

AbbVie Inc.'s (NYSE:ABBV) high institutional ownership speaks for itself as stock continues to impress, up 9.4% over last week
ABBV

Simply Wall St.

17 days ago

AbbVie Inc.'s (NYSE:ABBV) high institutional ownership speaks for itself as stock continues to impress, up 9.4% over last week

Jim Cramer Says AbbVie Inc. (ABBV) Is A ‘Buy’
ABBV

Insider Monkey

17 days ago

Jim Cramer Says AbbVie Inc. (ABBV) Is A ‘Buy’

AbbVie Rises 8% Since Q4 Earnings: Buy, Hold or Sell the Stock?
ABBV

Zacks

18 days ago

AbbVie Rises 8% Since Q4 Earnings: Buy, Hold or Sell the Stock?

Allergan Aesthetics, the American Society of Plastic Surgeons (ASPS) and The Aesthetic Society Release Two New Engaging LIMITLESS Videos Celebrating Women Surgeons
ABBV

PR Newswire

18 days ago

Allergan Aesthetics, the American Society of Plastic Surgeons (ASPS) and The Aesthetic Society Release Two New Engaging LIMITLESS Videos Celebrating Women Surgeons

Merck Is Suffering From a Classic Pharma Problem
ABBV

The Wall Street Journal

18 days ago

Merck Is Suffering From a Classic Pharma Problem

Analysts reset AbbVie stock price target after earnings
ABBV

TheStreet

19 days ago

Analysts reset AbbVie stock price target after earnings

ABBV

MT Newswires

19 days ago

Daiwa Securities Adjusts Price Target on AbbVie to $190 From $180, Keeps Neutral Rating

Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value
ABBV

GuruFocus.com

19 days ago

Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value

S&P 500 Gains and Losses Today: Index Falls Following Tariff Announcements
ABBV

Investopedia

19 days ago

S&P 500 Gains and Losses Today: Index Falls Following Tariff Announcements

ABBV

MT Newswires

20 days ago

UBS Adjusts Price Target on AbbVie to $190 From $181, Maintains Neutral Rating

Company News for Feb 3, 2025
ABBV

Zacks

20 days ago

Company News for Feb 3, 2025

ABBV

MT Newswires

20 days ago

Truist Securities Adjusts AbbVie Price Target to $217 From $211, Maintains Buy Rating

Why Investors Need to Take Advantage of These 2 Medical Stocks Now
ABBV

Zacks

20 days ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

ABBV

MT Newswires

20 days ago

Deutsche Bank Adjusts AbbVie Price Target to $173 From $177, Maintains Hold Rating

ABBV

Argus Research

20 days ago

Analyst Report: AbbVie Inc

ABBV

MT Newswires

20 days ago

Leerink Adjusts Price Target on AbbVie to $210 From $206, Maintains Outperform Rating

ABBV

Argus Research

20 days ago

Market Digest: SNY, BX, CLS, FL, GE, MSFT, NFG, SHEL, SYK, WBA, WM, WY, ABBV, BKR

ABBV

MT Newswires

20 days ago

Goldman Sachs Adjusts Price Target on AbbVie to $212 From $208, Keeps Buy Rating

ABBV

MT Newswires

20 days ago

Guggenheim Adjusts Price Target on AbbVie to $214 From $212, Keeps Buy Rating

ABBV

MT Newswires

20 days ago

Raymond James Adjusts Price Target on AbbVie to $220 From $218, Keeps Outperform Rating

ABBV

MT Newswires

20 days ago

Wells Fargo Adjusts Price Target on AbbVie to $210 From $195, Keeps Overweight Rating

Can AbbVie Inc.'s (NYSE:ABBV) ROE Continue To Surpass The Industry Average?
ABBV

Simply Wall St.

21 days ago

Can AbbVie Inc.'s (NYSE:ABBV) ROE Continue To Surpass The Industry Average?

Want $1 Million in Retirement? 2 Stocks to Buy Now and Hold for Decades.
ABBV

Motley Fool

22 days ago

Want $1 Million in Retirement? 2 Stocks to Buy Now and Hold for Decades.

AbbVie Inc (ABBV) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook
ABBV

GuruFocus.com

22 days ago

AbbVie Inc (ABBV) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook

ABBV

Thomson Reuters StreetEvents

22 days ago

Q4 2024 AbbVie Inc Earnings Call

AbbVie Surges 5% As Immunology Powerhouses Skyrizi And Rinvoq Continue To Dominate
ABBV

Investor's Business Daily

22 days ago

AbbVie Surges 5% As Immunology Powerhouses Skyrizi And Rinvoq Continue To Dominate

ABBV

MT Newswires

22 days ago

Sector Update: Health Care Stocks Fall Friday

Top Dividend Stocks Yielding As High As 5%: Fidelity
ABBV

Investor's Business Daily

22 days ago

Top Dividend Stocks Yielding As High As 5%: Fidelity

AbbVie (NYSE:ABBV) Posts Better-Than-Expected Sales In Q4, Stock Soars
ABBV

StockStory

22 days ago

AbbVie (NYSE:ABBV) Posts Better-Than-Expected Sales In Q4, Stock Soars

ABBV

MT Newswires

22 days ago

Sector Update: Health Care Stocks Higher Friday Afternoon

AbbVie Jumps After Q4 Earnings Beat, Skyrizi And Rinvoq Boom Offsets Humira Decline
ABBV

Benzinga

23 days ago

AbbVie Jumps After Q4 Earnings Beat, Skyrizi And Rinvoq Boom Offsets Humira Decline

AbbVie Jumps After Its Powerhouses, Skyrizi And Rinvoq, Continued To Dominate
ABBV

Investor's Business Daily

23 days ago

AbbVie Jumps After Its Powerhouses, Skyrizi And Rinvoq, Continued To Dominate

AbbVie Stock Jumps on Earnings and Revenue Beat
ABBV

Barrons.com

23 days ago

AbbVie Stock Jumps on Earnings and Revenue Beat

ABBV

Investing.com

23 days ago

AbbVie stock rises on solid annual profit guidance, Q4 beat

ABBV

MT Newswires

23 days ago

AbbVie's Q4 Adjusted Earnings Fall, Revenue Rises; Offers Full-Year 2025 Adjusted Earnings Guidance

ABBV

Associated Press Finance

23 days ago

AbbVie: Q4 Earnings Snapshot

AbbVie forecasts 2025 profit above estimates on newer immunology drugs
ABBV

Reuters

23 days ago

AbbVie forecasts 2025 profit above estimates on newer immunology drugs

AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results
ABBV

PR Newswire

23 days ago

AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results

Is AbbVie Inc. (ABBV) the Best Stock to Buy in 2025 for Beginners?
ABBV

Insider Monkey

25 days ago

Is AbbVie Inc. (ABBV) the Best Stock to Buy in 2025 for Beginners?

Allergan Aesthetics launches new AA Signature Program at IMCAS 2025 to redefine patient-centric, multimodal treatment plans
ABBV

PR Newswire

25 days ago

Allergan Aesthetics launches new AA Signature Program at IMCAS 2025 to redefine patient-centric, multimodal treatment plans

Merck (MRK) Earnings Expected to Grow: Should You Buy?
ABBV

Zacks

a month ago

Merck (MRK) Earnings Expected to Grow: Should You Buy?

High Growth Tech Stocks to Watch in January 2025
ABBV

Simply Wall St.

a month ago

High Growth Tech Stocks to Watch in January 2025

AbbVie Q4 Earnings Loom: Buy or Sell ABBV Stock Ahead of Results?
ABBV

Zacks

a month ago

AbbVie Q4 Earnings Loom: Buy or Sell ABBV Stock Ahead of Results?

ABBV

MT Newswires

a month ago

Citigroup Adjusts Price Target on AbbVie to $205 From $215, Maintains Buy Rating

I Own 4 High-Yield Dividend Stocks. Here's Why I Own Each One.
ABBV

Motley Fool

a month ago

I Own 4 High-Yield Dividend Stocks. Here's Why I Own Each One.

Navigating Market Uncertainty: Intrinsic Value of AbbVie Inc
ABBV

GuruFocus.com

a month ago

Navigating Market Uncertainty: Intrinsic Value of AbbVie Inc

Why AbbVie Stock Popped While the Market Flopped on Monday
ABBV

Motley Fool

a month ago

Why AbbVie Stock Popped While the Market Flopped on Monday

ABBV

Zacks

a month ago

5 Must-See Stocks with Perfect Earnings Charts

Do Options Traders Know Something About AbbVie (ABBV) Stock We Don't?
ABBV

Zacks

a month ago

Do Options Traders Know Something About AbbVie (ABBV) Stock We Don't?

ABBV

MT Newswires

a month ago

Piper Sandler Adjusts Price Target on AbbVie to $227 From $220, Keeps Overweight Rating

ABBV

MT Newswires

a month ago

Goldman Sachs Adjusts Price Target on AbbVie to $208 From $205, Keeps Buy Rating

Is AbbVie Inc. (ABBV) The Best Bear Market Stock To Invest In Now?
ABBV

Insider Monkey

a month ago

Is AbbVie Inc. (ABBV) The Best Bear Market Stock To Invest In Now?

AbbVie (ABBV) Stock Moves -0.22%: What You Should Know
ABBV

Zacks

a month ago

AbbVie (ABBV) Stock Moves -0.22%: What You Should Know

Pharma Stock Roundup: JNJ's Q4 Earnings, FDA Nod to AZN, Daiichi Drug
ABBV

Zacks

a month ago

Pharma Stock Roundup: JNJ's Q4 Earnings, FDA Nod to AZN, Daiichi Drug

Earnings Preview: AbbVie (ABBV) Q4 Earnings Expected to Decline
ABBV

Zacks

a month ago

Earnings Preview: AbbVie (ABBV) Q4 Earnings Expected to Decline

AbbVie Inks a Deal With Neomorph for Molecular Glue Degraders
ABBV

Zacks

a month ago

AbbVie Inks a Deal With Neomorph for Molecular Glue Degraders

Share on Social Networks: